BENDHEIM JACK (President and CEO) sold 5.2% of their position (5.28K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $258.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/16/2026ACC: 0001104659-26-028472
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-5.28K
Net shares
Net seller
$258.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
100K acquired · 105.28K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
+100K
Price / share
—
Trade value
—
% of position
6756.8%
3/12/2026
1.48K→101.48K
Class A Common Stock
Indirect
Shares
−5.28K
Price / share
$48.91
Trade value
$258.24K
% of position
5.2%
3/13/2026
101.48K→96.20K
Total
Net shares
+94.72K
Net value
-$258.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 3/12/2026 | C · Conversion | +100K | — | — | 6756.8% | 1.48K | 101.48K |
| Class A Common Stock Indirect | 3/13/2026 | S · Sale | −5.28K | $48.91 | $258.24K | 5.2% | 101.48K | 96.20K |
| Total | +94.72K | -$258.24K | ||||||
Derivative Transactions1
Class B Common Stock
Indirect
Converts to
Class A Common Stock
100K shares
Shares
−100K
Strike price
0
Held after
19.60M
Exercisable
—
3/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Indirect | Class A Common Stock100K shares | 3/12/2026 | C · Conversion | −100K | 0 | — | 19.60M |
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported